Since DPP-4 rapidly cleaves and inactivates the incretin hormones (GLP-1 and GIP), which are essential for glucose regulation, its blockade has been investigated as a way of ameliorating glycemia in diabetes through preservation of the impaired incretin action [7]. The gene discussed is GLP1R; the disease is diabetes mellitus.